CRL vs. DHR
Compare and contrast key facts about Charles River Laboratories International, Inc. (CRL) and Danaher Corporation (DHR).
Performance
CRL vs. DHR - Performance Comparison
Loading graphics...
CRL vs. DHR - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
CRL Charles River Laboratories International, Inc. | -13.53% | 8.06% | -21.91% | 8.49% | -42.17% | 50.80% | 63.56% | 34.97% | 3.41% | 43.65% |
DHR Danaher Corporation | -17.00% | 0.35% | -0.35% | -1.22% | -19.02% | 48.57% | 45.34% | 49.55% | 11.80% | 20.01% |
Fundamentals
CRL:
$8.49B
DHR:
$134.81B
CRL:
-$2.93
DHR:
$5.06
CRL:
2.12
DHR:
5.51
CRL:
2.68
DHR:
2.57
CRL:
$4.02B
DHR:
$24.57B
CRL:
$1.01B
DHR:
$14.97B
CRL:
$319.45M
DHR:
$7.02B
Returns By Period
In the year-to-date period, CRL achieves a -13.53% return, which is significantly higher than DHR's -17.00% return. Over the past 10 years, CRL has underperformed DHR with an annualized return of 8.32%, while DHR has yielded a comparatively higher 12.00% annualized return.
CRL
- 1D
- 8.00%
- 1M
- -3.36%
- YTD
- -13.53%
- 6M
- 10.25%
- 1Y
- 14.60%
- 3Y*
- -5.10%
- 5Y*
- -10.13%
- 10Y*
- 8.32%
DHR
- 1D
- 3.11%
- 1M
- -9.80%
- YTD
- -17.00%
- 6M
- -4.03%
- 1Y
- -6.87%
- 3Y*
- -4.81%
- 5Y*
- -0.55%
- 10Y*
- 12.00%
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
CRL vs. DHR — Risk / Return Rank
CRL
DHR
CRL vs. DHR - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Charles River Laboratories International, Inc. (CRL) and Danaher Corporation (DHR). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| CRL | DHR | Difference | |
|---|---|---|---|
Sharpe ratioReturn per unit of total volatility | 0.26 | -0.21 | +0.47 |
Sortino ratioReturn per unit of downside risk | 0.73 | -0.09 | +0.81 |
Omega ratioGain probability vs. loss probability | 1.12 | 0.99 | +0.13 |
Calmar ratioReturn relative to maximum drawdown | 0.32 | -0.29 | +0.62 |
Martin ratioReturn relative to average drawdown | 0.74 | -0.87 | +1.61 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading graphics...
Sharpe Ratios by Period
| CRL | DHR | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | 0.26 | -0.21 | +0.47 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | -0.24 | -0.02 | -0.22 |
Sharpe Ratio (10Y)Calculated over the trailing 10-year period | 0.22 | 0.48 | -0.25 |
Sharpe Ratio (All Time)Calculated using the full available price history | 0.23 | 0.65 | -0.42 |
Correlation
The correlation between CRL and DHR is 0.44, which is considered to be moderate. This suggests that the two assets have some degree of positive relationship in their price movements. Moderate correlation can be acceptable for portfolio diversification, offering a balance between risk and potential returns.
Dividends
CRL vs. DHR - Dividend Comparison
CRL has not paid dividends to shareholders, while DHR's dividend yield for the trailing twelve months is around 0.72%.
| TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
CRL Charles River Laboratories International, Inc. | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
DHR Danaher Corporation | 0.72% | 0.56% | 0.47% | 12.64% | 0.38% | 0.26% | 0.32% | 0.44% | 0.62% | 0.60% | 32.55% | 0.58% |
Drawdowns
CRL vs. DHR - Drawdown Comparison
The maximum CRL drawdown since its inception was -78.23%, which is greater than DHR's maximum drawdown of -45.80%. Use the drawdown chart below to compare losses from any high point for CRL and DHR.
Loading graphics...
Drawdown Indicators
| CRL | DHR | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -78.23% | -45.80% | -32.43% |
Max Drawdown (1Y)Largest decline over 1 year | -33.18% | -24.85% | -8.33% |
Max Drawdown (5Y)Largest decline over 5 years | -78.23% | -39.81% | -38.42% |
Max Drawdown (10Y)Largest decline over 10 years | -78.23% | -39.81% | -38.42% |
Current DrawdownCurrent decline from peak | -62.36% | -34.20% | -28.16% |
Average DrawdownAverage peak-to-trough decline | -25.47% | -10.08% | -15.39% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 14.67% | 8.34% | +6.33% |
Volatility
CRL vs. DHR - Volatility Comparison
Charles River Laboratories International, Inc. (CRL) has a higher volatility of 17.13% compared to Danaher Corporation (DHR) at 8.93%. This indicates that CRL's price experiences larger fluctuations and is considered to be riskier than DHR based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading graphics...
Volatility by Period
| CRL | DHR | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 17.13% | 8.93% | +8.20% |
Volatility (6M)Calculated over the trailing 6-month period | 32.68% | 20.17% | +12.51% |
Volatility (1Y)Calculated over the trailing 1-year period | 56.65% | 32.45% | +24.20% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 41.85% | 27.75% | +14.10% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 37.20% | 25.24% | +11.96% |
Financials
CRL vs. DHR - Financials Comparison
This section allows you to compare key financial metrics between Charles River Laboratories International, Inc. and Danaher Corporation. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
CRL vs. DHR - Profitability Comparison
CRL - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Apr 2026, Charles River Laboratories International, Inc. reported a gross profit of 0.00 and revenue of 994.23M. Therefore, the gross margin over that period was 0.0%.
DHR - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Apr 2026, Danaher Corporation reported a gross profit of 3.97B and revenue of 6.84B. Therefore, the gross margin over that period was 58.0%.
CRL - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Apr 2026, Charles River Laboratories International, Inc. reported an operating income of -283.44M and revenue of 994.23M, resulting in an operating margin of -28.5%.
DHR - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Apr 2026, Danaher Corporation reported an operating income of 1.50B and revenue of 6.84B, resulting in an operating margin of 22.0%.
CRL - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Apr 2026, Charles River Laboratories International, Inc. reported a net income of -276.56M and revenue of 994.23M, resulting in a net margin of -27.8%.
DHR - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Apr 2026, Danaher Corporation reported a net income of 1.20B and revenue of 6.84B, resulting in a net margin of 17.5%.